181 related articles for article (PubMed ID: 24758908)
41. Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Pan G; Ke S; Zhao J
Target Oncol; 2013 Jun; 8(2):107-16. PubMed ID: 23516098
[TBL] [Abstract][Full Text] [Related]
42. [A meta-analysis of pemetrexed plus platinum chemotherapy versus gemcitabine plus platinum chemotherapy for advanced non-small cell lung cancer].
Jiang J; Li L; Wang X; Tian J; Wang Q; Lin Q
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):43-8. PubMed ID: 21219831
[TBL] [Abstract][Full Text] [Related]
43. Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.
Martoni A; Guaraldi M; Piana E; Strocchi E; Petralia A; Busutti L; Preti P; Robustelli G; Raimondi M; Ferrara G; Palomba G; Lelli G; Picece V; Recaldin E; Caffo O; Ambrosini G; Sarobba G; Farris A; Pannuti F
Lung Cancer; 1998 Oct; 22(1):31-8. PubMed ID: 9869105
[TBL] [Abstract][Full Text] [Related]
44. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
Chen YM; Perng RP; Shih JF; Tsai CM; Whang-Peng J
Lung Cancer; 2007 Jun; 56(3):363-9. PubMed ID: 17306906
[TBL] [Abstract][Full Text] [Related]
45. [Intercalated Combination of Chemotherapy and EGFR-TKIs versus Chemotherapy Alone in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis].
Hong C; Mei T; Wang J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):837-846. PubMed ID: 27978869
[TBL] [Abstract][Full Text] [Related]
46. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
Belani C;
Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
[TBL] [Abstract][Full Text] [Related]
47. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
[TBL] [Abstract][Full Text] [Related]
48. A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer.
Bennouna J; Monnier A; Rivière A; Milleron B; Lemarie E; Trillet-Lenoir V; Soussan-Lazard K; Berille J; Douillard JY
Eur J Cancer; 2000 Jun; 36(9):1107-12. PubMed ID: 10854943
[TBL] [Abstract][Full Text] [Related]
49. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
[TBL] [Abstract][Full Text] [Related]
50. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
Bennouna J; Havel L; Krzakowski M; Kollmeier J; Gervais R; Dansin E; Serke M; Favaretto A; Szczesna A; Cobo M; Ciuffreda L; Jassem J; Nicolini M; Ramlau R; Amoroso D; Melotti B; Almodovar T; Riggi M; Caux NR; Vaissière N; Tan EH
Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
[TBL] [Abstract][Full Text] [Related]
51. Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Li M; Zhang Q; Fu P; Li P; Peng A; Zhang G; Song X; Tan M; Li X; Liu Y; Wu Y; Fan S; Wang C
PLoS One; 2012; 7(5):e37229. PubMed ID: 22615946
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs.
Li J; Li HZ; Zhu GH; Gao RK; Zhang Y; Hou W; Li J
Ann Palliat Med; 2020 Jul; 9(4):1518-1535. PubMed ID: 32692199
[TBL] [Abstract][Full Text] [Related]
53. A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer.
Pilkington G; Boland A; Brown T; Oyee J; Bagust A; Dickson R
Thorax; 2015 Apr; 70(4):359-67. PubMed ID: 25661113
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.
Des Guetz G; Uzzan B; Nicolas P; Valeyre D; Sebbane G; Morere JF
Crit Rev Oncol Hematol; 2012 Dec; 84(3):340-9. PubMed ID: 22534083
[TBL] [Abstract][Full Text] [Related]
55. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.
Lilenbaum RC; Langenberg P; Dickersin K
Cancer; 1998 Jan; 82(1):116-26. PubMed ID: 9428487
[TBL] [Abstract][Full Text] [Related]
56. Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.
Monnet I; de CH; Soulié P; Saltiel-Voisin S; Bekradda M; Saltiel JC; Brain E; Rixe O; Yataghene Y; Misset JL; Cvitkovic E
Ann Oncol; 2002 Jan; 13(1):103-7. PubMed ID: 11863089
[TBL] [Abstract][Full Text] [Related]
57. Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
Gebbia V; Gridelli C; Verusio C; Frontini L; Aitini E; Daniele B; Gamucci T; Mancuso G; Di Maio M; Gallo C; Perrone F; Morabito A
Lung Cancer; 2009 Feb; 63(2):251-8. PubMed ID: 18632181
[TBL] [Abstract][Full Text] [Related]
58. A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy.
Yoh K; Hosomi Y; Kasahara K; Yamada K; Takahashi T; Yamamoto N; Nishio M; Ohe Y; Koue T; Nakamura T; Enatsu S; Lee P; Ferry D; Tamura T; Nakagawa K
Lung Cancer; 2016 Sep; 99():186-93. PubMed ID: 27565938
[TBL] [Abstract][Full Text] [Related]
59. Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis.
Cao A; He H; Wang Q; Li L; An Y; Zhou X
Medicine (Baltimore); 2019 Mar; 98(11):e14798. PubMed ID: 30882655
[TBL] [Abstract][Full Text] [Related]
60. Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review.
Dong J; Su SY; Wang MY; Zhan Z
J Exp Clin Cancer Res; 2010 Oct; 29(1):137. PubMed ID: 20969765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]